Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2018 | Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing. | Sun, LL; Yang, RY; Li, CW; Chen, MK; Shao, B; Hsu, JM; Chan, LC; Yang, Y; Hsu, JL; Lai, YJ; Hung, MC | American journal of cancer research 8(7), 1307-1316 | | | |
2016 | Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis | Chen, CK; Yu, WH; Cheng, TY; Chen, MW; Su, CY; Yang, YC; Kuo, TC; Lin, MT; Hsiao, M; Hua, KT; Hung, MC; Kuo, ML | Scientific Reports 6, 31398 | | | |
2014 | MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. | Thirumurthi, U; Shen, J; Xia, W; LaBaff, AM; Wei, Y; Li, CW; Chang, WC; Chen, CH; Lin, HK; Yu, D; Hung, MC | Science signaling 7(336), ra71 | | | |
2013 | Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. | Huang, WH; Chang, MC; Tsai, KS; Hung, MC; Chen, HL; Hung, SC | ONCOGENE 32(37), 4343-54 | | | |
2019 | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | Li, H; Li, CW ; Li, X; Ding, Q; Guo, L; Liu, S; Liu, C; Lai, CC; Hsu, JM; Dong, Q; Xia, W; Hsu, JL; Yamaguchi, H; Du, Y; Lai, YJ; Sun, X; Koller, PB; Ye, Q; Hung, MC | Gastroenterology 156(6), 1849-1861.e13 | | | |
2018 | Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. | Cha, JH; Yang, WH; Xia, W; Wei, Y; Chan, LC; Lim, SO; Li, CW; Kim, T; Chang, SS; Lee, HH; Hsu, JL; Wang, HL; Kuo, CW; Chang, WC; Hadad, S; Purdie, CA; McCoy, AM; Cai, S; Tu, Y; Litton, JK; Mittendorf, EA; Moulder, SL; Symmans, WF; Thompson, AM; Piwnica-Worms, H; Chen, CH; Khoo, KH ; Hung, MC | Molecular cell 71(4), 606-620.e7 | | | |
2013 | MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. | Yu, YH; Chen, HA; Chen, PS; Cheng, YJ; Hsu, WH; Chang, YW; Chen, YH; Jan, Y; Hsiao, M; Chang, TY; Liu, YH; Jeng, YM; Wu, CH; Huang, MT; Su, YH; Hung, MC; Chien, MH; Chen, CY; Kuo, ML; Su, JL | Oncogene Jan 24;32(4):431-43 | | | |
2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | | | |
2011 | p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. | Chang, CJ; Chao, CH; Xia, W; Yang, JY; Xiong, Y; Li, CW ; Yu, WH; Rehman, SK; Hsu, JL; Lee, HH; Liu, M; Chen, CT; Yu, D; Hung, MC | Nature cell biology 13(3), 317-323 | | | |
2019 | Palmitoylation stabilizes PD-L1 to promote breast tumor growth. | Yang, Y; Hsu, JM; Sun, L; Chan, LC; Li, CW ; Hsu, JL; Wei, Y; Xia, W; Hou, J; Qiu, Y; Hung, MC | Cell research 29(1), 83-86 | | | |
2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
2022 | Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2 | Wang, WJ; Chen, Y; Su, WC; Liu, YY; Shen, WJ; Chang, WC; Huang, ST; Lin, CW; Wang, YC; Yang, CS; Hou, MH; Chou, YC ; Wu, YC; Wang, SC; Hung, MC | Journal of food biochemistry 46(10), e14354 | | | |
2018 | Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy. | Hsu, JM; Li, CW; Lai, YJ; Hung, MC | Cancer research 78(22), 6349-6353 | | | |
2022 | Prospects of Coffee Leaf against SARS-CoV-2 Infection. | Wu, CS; Chiang, HM; Chen, Y; Chen, CY; Chen, HF; Su, WC; Wang, WJ; Chou, YC ; Chang, WC; Wang, SC; Hung, MC | International journal of biological sciences 18(12), 4677-4689 | | | |
2017 | Rational combination of immunotherapy for triple negative breast cancer treatment. | Li, CW ; Lim, SO; Hsu, JL; Hung, MC | Chinese clinical oncology 6(5), 54 | | | |
2010 | RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus. | Huo, L; Wang, YN; Xia, W; Hsu, SC; Lai, CC; Li, LY; Chang, WC; Wang, Y; Hsu, MC; Yu, YL; Huang, TH; Ding, Q; Chen, CH; Tsai, CH; Hung, MC | Proceedings of the National Academy of Sciences of the United States of America 107(37), 16125-16130 | | | |
2015 | Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells. | Rahal, OM; Nie, L; Chan, LC; Li, CW ; Hsu, YH; Hsu, J; Yu, D; Hung, MC | American journal of cancer research 5(12), 3624-3634 | | | |
2016 | Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection. | Wu, TJ; Chang, SS; Li, CW ; Hsu, YH; Chen, TC; Lee, WC; Yeh, CT; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 22(7), 1800-1812 | | | |
2013 | Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. | Yu, YL; Chou, RH; Shyu, WC; Hsieh, SC; Wu, CS; Chiang, SY; Chang, WJ; Chen, JN; Tseng, YJ; Lin, YH; Lee, W; Yeh, SP; Hsu, JL; Yang, CC; Hung, SC; Hung, MC | EMBO molecular medicine 5(4), 531-47 | | | |
2018 | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | Hsu, JM; Xia, W; Hsu, YH; Chan, LC; Yu, WH; Cha, JH; Chen, CT; Liao, HW; Kuo, CW; Khoo, KH ; Hsu, JL; Li, CW; Lim, SO; Chang, SS; Chen, YC; Ren, GX; Hung, MC | Nature communications 9(1), 1908 | | | |